CKD-581, a novel histone deacetylase inhibitor, synergistically enhances Bortezomib cytotoxicity in multiple myeloma cells

被引:1
|
作者
Lee, Chansu [1 ]
Ahn, Kwang-Sung [2 ]
Jung, Woo June [1 ]
Koh, Youngil [2 ]
Kim, Hyo Jung [3 ]
Lee, Hyun Jung [4 ]
Yoon, Hwi-Joong [5 ]
Yoon, Sung-Soo [6 ]
机构
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[3] Hallym Univ, Coll Med, Med Ctr, Seoul, South Korea
[4] Dongguk Univ, Ilsan Med Ctr, Seoul, South Korea
[5] Kyung Hee Univ, Sch Med, Med Ctr, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Seoul, South Korea
关键词
D O I
10.1158/1538-7445.AM2014-1695
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1695
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma
    Imai, Yoichi
    Ohta, Eri
    Takeda, Shu
    Sunamura, Satoko
    Ishibashi, Mariko
    Tamura, Hideto
    Wang, Yan-hua
    Deguchi, Atsuko
    Tanaka, Junji
    Maru, Yoshiro
    Motoji, Toshiko
    JCI INSIGHT, 2016, 1 (05):
  • [32] Panobinostat: A histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma
    Wahaib, Kristy
    Beggs, Ashton E.
    Campbell, Hope
    Kodali, Leela
    Ford, Patrick D.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (07) : 441 - 450
  • [33] Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
    J Minami
    R Suzuki
    R Mazitschek
    G Gorgun
    B Ghosh
    D Cirstea
    Y Hu
    N Mimura
    H Ohguchi
    F Cottini
    J Jakubikova
    N C Munshi
    S J Haggarty
    P G Richardson
    T Hideshima
    K C Anderson
    Leukemia, 2014, 28 : 680 - 689
  • [34] Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
    Minami, J.
    Suzuki, R.
    Mazitschek, R.
    Gorgun, G.
    Ghosh, B.
    Cirstea, D.
    Hu, Y.
    Mimura, N.
    Ohguchi, H.
    Cottini, F.
    Jakubikova, J.
    Munshi, N. C.
    Haggarty, S. J.
    Richardson, P. G.
    Hideshima, T.
    Anderson, K. C.
    LEUKEMIA, 2014, 28 (03) : 680 - 689
  • [35] Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
    Starheim, K. K.
    Holien, T.
    Misund, K.
    Johansson, I.
    Baranowska, K. A.
    Sponaas, A-M
    Hella, H.
    Buene, G.
    Waage, A.
    Sundan, A.
    Bjorkoy, G.
    BLOOD CANCER JOURNAL, 2016, 6 : e446 - e446
  • [36] Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
    K K Starheim
    T Holien
    K Misund
    I Johansson
    K A Baranowska
    A-M Sponaas
    H Hella
    G Buene
    A Waage
    A Sundan
    G Bjørkøy
    Blood Cancer Journal, 2016, 6 : e446 - e446
  • [37] The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
    Mandl-Weber, Sonja
    Meinel, Felix G.
    Jankowsky, Ruediger
    Oduncu, Fuat
    Schmidmaier, Ralf
    Baumann, Philipp
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 518 - 528
  • [38] Synergistic induction of apoptosis in HeLa cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitor SAHA
    Jiang, Yizhou
    Wang, Yi
    Su, Zijie
    Yang, Ling
    Guo, Weiwei
    Liu, Wen
    Zuo, Ji
    MOLECULAR MEDICINE REPORTS, 2010, 3 (04) : 613 - 619
  • [39] Pterostilbene: A Novel Histone Deacetylase 1 Inhibitor (HDACi1) Demonstrating Efficacy in Multiple Myeloma
    Chen, Haiming
    Hao, Rui
    Sanchez, Eric
    Shen, Jing
    Li, Mingjie
    Wang, Jessica
    Wong, Emily
    Adler, Anoushka
    Hu, Mengyin
    Leung, Crystal
    Wang, Cathy S.
    Li, Zhi-Wei
    Bonavida, Benjamin
    Berenson, James R.
    BLOOD, 2009, 114 (22) : 1478 - 1479
  • [40] Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
    Mujtaba, Taskeen
    Kanwar, Jyoti
    Wan, Sheng Biao
    Chan, Tak Hang
    Dou, Q. Ping
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 29 (01) : 102 - 106